Abstract
Background Tuberculosis (TB) is a major public health challenge in developing countries, where Tanzania is one of them. The presence of under-nutrition exacerbates disease progression and impairs treatment outcomes. Nutritional support has been increasingly recognized as a vital component of TB care, yet the evidence from interventional and operational studies remains fragmented. This systematic review aims to synthesize current evidence on the impact of nutritional interventions on TB treatment outcomes and recovery in Tanzania.
Methods A comprehensive literature search was conducted across major databases including PubMed, Embase, Scopus, Web of Science and others which covered studies published from January 2000 to June 2025. Eligible studies included randomized controlled trials, quasi-experimental designs, and operational research evaluating the effect of nutritional interventions, such as food supplements, micronutrient support, and therapeutic feeding on TB treatment outcomes (eg. cure rate, treatment completion, mortality) and recovery indicators (e.g., weight gain, immune response) among TB patients in developing countries. Risks of bias and study quality were assessed using standardized tools.
Results A total of 18 studies involving approximately 5007 participants are included, the majority of which reported positive associations between nutritional interventions and improved treatment outcomes including: higher treatment completion rates, enhanced weight gain, and reduced mortality. Micronutrient supplementation showed variable effects, while macronutrient and food-based interventions demonstrated more consistent benefits. Operational studies revealed challenges in implementation and sustainability, particularly in resource-limited settings.
Conclusions Nutritional interventions play a critical role in enhancing TB treatment success and patient recovery. Integrating tailored nutritional support into routine TB care could improve health outcomes. Further large-scale, high-quality operational studies are needed to guide policy and program implementation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
